Literature DB >> 6109323

Biochemical and genetical approaches to the mechanism of action of penicillin.

B G Spratt.   

Abstract

Since the discovery in 1965 that penicillin inhibits the transpeptidation reaction in peptidoglycan synthesis, a considerable effort has been put into the purification of enzymes that catalyse this reaction. This has resulted in the recognition that bacteria possess multiple forms of these penicillin-sensitive enzymes and has made it difficult to identify the precise target that penicillin inactivates to kill the organism. Recently penicillin-sensitive enzymes have been detected and studies as penicillin-binding proteins on sodium dodecyl sulphate polyacrylamide gels. The availability of this convenient method for identifying penicillin-sensitive enzymes has allowed biochemical and genetical approaches to be used to dissect their roles in the lethal effects of penicillin and other beta-lactam antibiotics. Three penicillin-binding proteins (1 B, 2 and 3) have been identified as killing targets for penicillin in Escherichia coli, whereas four other binding proteins are not implicated in the mechanism of action of the antibiotic. The complex biological effects that beta-lactam antibiotics produce on the growth of E. coli can be explained by their interaction with the three killing targets. Progress in the correlation of penicillin-binding proteins with penicillin-sensitive enzymes and in the development of strains of E. coli that overproduce penicillin-binding proteins is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109323     DOI: 10.1098/rstb.1980.0045

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  28 in total

Review 1.  Consequences of the interaction of beta-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains.

Authors:  H Labischinski
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

2.  Identification of two new cell division genes that affect a high-molecular-weight penicillin-binding protein in Caulobacter crescentus.

Authors:  P Nathan; A Newton
Journal:  J Bacteriol       Date:  1988-05       Impact factor: 3.490

3.  In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Y Sumita; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 4.  Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin.

Authors:  P Giesbrecht; T Kersten; H Maidhof; J Wecke
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  Alterations in peptidoglycan of Neisseria gonorrhoeae induced by sub-MICs of beta-lactam antibiotics.

Authors:  J F Garcia-Bustos; T J Dougherty
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  Cloning and expression of the ponB gene, encoding penicillin-binding protein 1B of Escherichia coli, in heterologous systems.

Authors:  J Plá; F Rojo; M A de Pedro; J A Ayala
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

7.  Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus.

Authors:  Y Sumita; M Fukasawa; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

8.  Increased susceptibility to cephamycin-type antibiotics of methicillin-resistant Staphylococcus aureus defective in penicillin-binding protein 2.

Authors:  K Murakami; K Nomura; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

9.  In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic.

Authors:  M Matsumoto; H Tamaoka; H Ishikawa; M Kikuchi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  G A de Koning; D Tio; J A van den Hoek; B van Klingeren
Journal:  Br J Vener Dis       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.